Adverse pregnancy outcomes in adult patients with idiopathic inflammatory myopathy: a systematic review and meta-analysis.

Semi-quantitative analyses of muscle magnetic resonance imaging for pattern recognition in early idiopathic inflammatory myopathies.

Muscle MR Radiomics for Evaluation of Idiopathic Inflammatory Myopathies.

Validating the effectiveness of The International Myositis Assessment and Clinical Studies Group (IMACS) idiopathic inflammatory myopathy cancer screening guidelines in a Singapore cohort.

Global landscape of juvenile dermatomyositis research: a bibliometric analysis.

A case of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with a challenging diagnosis due to the absence of typical skin manifestations.

CAR-T therapy for autoimmune rheumatic diseases: navigating clinical frontiers between breakthroughs and uncertainties.

Nerandomilast attenuates idiopathic inflammatory myopathy-associated interstitial lung disease via inhibiting proliferation and differentiation of B cells.

An interpretable machine learning model integrating clinical and CT radiomic features for the detection of interstitial lung disease in idiopathic inflammatory myopathies.

HLA variation analysis and autoantigen epitope prediction in idiopathic inflammatory myopathies.

Antisynthetase Syndrome Mimicking Pulmonary Infection: A Diagnostic Lesson From County-Managed Hospital.

Fitbit as an activity monitor in idiopathic inflammatory myopathy: results from a real-world cohort.

Prophylactic Effect of Trimethoprim-sulfamethoxazole on Severe Infections in Idiopathic Inflammatory Myopathy.

Erythematous rash and proximal muscle weakness in a 59-year-old woman: Delayed diagnosis of dermatomyositis in a patient with skin of color.

Association between Oropharyngeal Dysphagia and Subgroups of Patients with Idiopathic Inflammatory Myopathy: A Cross-Sectional Study.

A Rare Case Report of Antisynthetase Syndrome With Progressive Myopathy and Interstitial Lung Disease in a 38-Year-Old Male.

Anlotinib ameliorates myositis-associated interstitial lung disease (MAILD) via suppression of the NETs-PI3K/Akt-driven epithelial-mesenchymal transition.

Interstitial lung disease in systemic autoimmune rheumatic diseases: radiologic and histologic correlations.

Development of enzyme-linked immunosorbent assays for the detection of myositis-specific autoantibodies against signal recognition particle, nuclear matrix protein 2, and small ubiquitin-like modifier activating enzyme.

The impact of vertebral fractures on pulmonary function tests in patients with interstitial lung disease: a cross-sectional study.

Identification of immune-related genes and serum miR-100-5p in idiopathic inflammatory myopathy-related heart failure by integrated bioinformatics analysis and clinical validation.

Kinematic features of dysphagia in inclusion body myositis.

Spontaneous remission in statin-associated HMGCR-positive immune-mediated necrotizing myopathy after statin withdrawal.

[Expression of the melanoma 2-mediated pyroptosis pathway in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies].

Idiopathic Inflammatory Myopathy With Normal Creatine Kinase Levels in an Elderly Patient: A Diagnostic Challenge.

Clinical Characteristics and Evolution of Interstitial Lung Disease in Subtypes of Idiopathic Inflammatory Myositis With Prevalent Lung Manifestation: A Retrospective Analysis.

Hyperglycemia-A Driver of Cutaneous Severity in Dermatomyositis: A Narrative Review.

A Diagnostic Delay: Respiratory Muscle Weakness in Dermatomyositis Masquerading as Pneumonia.

Different faces of anti-melanoma differentiation-associated gene 5 antibody-positive myositis.

Lung ultrasound B-line quantification in CTD-ILD: a cross-sectional single-center observational study.

Addressing cohort reliance in rare diseases literature: a scoping review of myositis research.

Prevalence and early detection of myocarditis in idiopathic inflammatory myopathies: a prospective single-centre study.

The distribution and clinical significance of anti-nuclear antibodies in patients with idiopathic inflammatory myopathy in Southwest China.

Multi-kingdom gut microbiota characterization in Chinese patients with idiopathic inflammatory myopathies.

Baricitinib alleviates myositis-associated interstitial lung disease in mice by inhibiting the NETs-cGAS-STING-EMT axis.

An Update on Dermatomyositis and Related Inflammatory Myopathies: Cutaneous Clues, Skeletal Muscle Involvement, and Advances in Pathogenesis and Treatment.

CT characterization of idiopathic inflammatory myopathy-associated interstitial lung disease: frontiers to strengthen diagnostic accuracyAuthors' ReplyA Review of Myositis-Associated Interstitial Lung Disease2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.

[Rheumatic disease spectrum and immunological profile of anti-PM/Scl antibodies in idiopathic inflammatory myopathies].

Anti-SRP antibody-positive polymyositis complicated by neuromyelitis optica spectrum disorder: a case report and literature review.

A pilot study of telitacicept in predominantly immune-mediated necrotizing myopathy, retrospective analysis of a monocentric Chinese cohort.

Targeted Therapy for Idiopathic Inflammatory Myopathy.

Inhibition of NOX4 attenuates muscle damage and mitochondrial dysfunction in inflammatory myopathy.

Rapidly Progressive Polymyositis With Vasculitis: The Pivotal Role of Histopathology in Diagnosis and Management.

Clinical features and prognosis of idiopathic inflammatory myopathy complicated by heart failure with preserved ejection fraction.

Circular RNAs and their emerging roles in muscular immune-related diseases.

Prognostic value of pulmonary vessel-related structures in rapid progression of idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study from two centres.

Clinical Significance of Fractional Exhaled Nitric Oxide (FeNO) Measurements in Juvenile Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease.

Retrospective analysis of myositis-specific antibody-positive veteran survival between 2011 and 2023.

Interleukin-33 Promotes Interstitial Lung Disease in Idiopathic Inflammatory Myopathy Via ERK-Mediated Epithelial-Mesenchymal Transition: ERK as a Potential Therapeutic Target.

Association of clinical features and myositis-specific antibodies in idiopathic inflammatory myopathy: a retrospective study from southern China.

Juvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications.

Increased prevalence and incidence of statin-associated immune-mediated necrotizing myopathy in Native Americans.

Cellular Therapy for Systemic Autoimmune Diseases: New Opportunities for Future Research and Interdisciplinary Collaboration.

Integrated metabolomic profiling identifies citrate as novel diagnostic biomarker for Anti-MDA5-Positive dermatomyositis.

Serum carcinoembryonic antigen levels correlate with disease severity and 1-year survival across different interstitial lung diseases subtypes.

Unmasking Idiopathic Inflammatory Myopathy: A Case of Proximal Weakness in a Young Male With Co-Occurring Vitamin D Deficiency.

Distinct cytokine signature in juvenile dermatomyositis: linking myositis-specific antibodies and clinical manifestations.

Progressive myalgia as the sole manifestation of cancer-associated myositis: A case report and review of the literature.

[Frequency of hypogonadism and clinical features of systemic sclerosis and idiopathic inflammatory myopathies in men depending on testosterone levels].

Antisynthetase syndrome causing progressive gait disturbance.

Emerging therapies in idiopathic inflammatory myopathies: Advances in treatment and future directions.

Relapse Rate After Glucocorticoid-Free Remission in Patients With Idiopathic Inflammatory Myopathies and Validation of the International Myositis Assessment and Clinical Studies Group Criteria for Complete Clinical Response and Worsening.

Statin-Associated Immune-Mediated Necrotizing Myopathy With Dual Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) and Anti-OJ Positivity: A Case Report of Fulminant Weakness and Respiratory Failure.

The SCRIM score: a clinical tool for cancer risk-stratification in patients with idiopathic inflammatory myopathy.

Longitudinal change of idiopathic inflammatory myopathy-associated interstitial lung disease on high-resolution computed tomography, a prospective cohort study.

Clinical, functional, and computed tomographic characterization of idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective cohort study.

Altered Iron Regulation and the Role of Ferritin Heavy Chain in Dermatomyositis Patients.

Chimeric Antigen Receptor (CAR) T Cell Therapy for Neuromuscular Disorders: A Systematic Review.

Emerging therapies in idiopathic inflammatory myopathies.

Mixed Multiple Autoimmune Syndrome Type 3 With Coexistence of Primary Biliary Cholangitis, Inflammatory Myopathy, and Chronic Thyroiditis: A Case Report.

The Clinical Features and Prognosis of Idiopathic and Infection-Triggered Acute Exacerbation of Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease: A Preliminary Study.

Regaining Gait Independence in Idiopathic Inflammatory Myopathy Patients With Inability to Ambulate.

Association of diastolic dysfunction with myocardial tissue characteristics assessed by multi-parameter cardiac magnetic resonance in patients with idiopathic inflammatory myopathy.

Discordance in Patient and Physician's Perception of Disease Activity Among Idiopathic Inflammatory Myopathy Patients: Insights From the COVAD Study.

When Sepsis Is Not Sepsis: A Case Report of Autoimmune Myopathy Masquerading as Postoperative Infection.

Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathy.

Cardiac Magnetic Resonance Imaging Markers in Idiopathic Inflammatory Myopathy: Correspondence.

Clinical characteristics and prognostic analysis of concurrent Pneumocystis jirovecii pneumonia in patients with connective tissue diseases: a retrospective study.

Diagnostic challenges of dermatomyositis in a resource-limited setting: a case report.

Identification of idiopathic inflammatory myopathy research cohorts using international classification of disease (ICD) codes: A systematic review.

Clinical features and recurrence risk prediction model in patients with idiopathic inflammatory myopathies-associated interstitial lung disease: a retrospective study from Ningbo.

Idiopathic inflammatory myopathy associated with Sjögren's disease: features of a distinct clinical entity.

Antisynthetase Syndrome Masquerading As Psoriasis and Psoriatic Arthritis: A Case Report.

Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis With Rapidly Progressive Interstitial Lung Disease Complicated by Pneumothorax, Pneumomediastinum, and Subcutaneous Emphysema: Clinical Course Compared With Reported Cases Worldwide.

Idiopathic Inflammatory Myopathy-Molecular Mechanisms Underlying Its Pathogenesis and Physical Therapy Effects.

Isolated Rapidly Progressive Interstitial Lung Disease Without Muscle or Skin Involvement in Idiopathic Inflammatory Myopathy: An Unusual Anti-Mi-2 Antibody Phenotype.

Myopathology and Immune Profile of Granulomatous Myositis in Sarcoid Myopathy.

A Scoping Review of Respiratory Dysfunction in Inclusion Body Myositis.

Biased Usage of V/D/J Genes and Clonal Diversity in IgG Repertoires Correlates with Disease Activity and Clinical Features in Systemic Autoimmune Diseases.

[Experiences after CD19-CAR T-cell therapy in non-SLE connective tissue diseases].

Characterization of Muscle Tissue Cell Diversity and Clinical Implications in Idiopathic Inflammatory Myopathy.

Pathogenesis and Treatment of Interstitial Lung Disease Accompanied by Anti-melanoma Differentiation-associated Gene 5-positive Idiopathic Inflammatory Myopathies.

Quantitative Imaging Markers on HRCT Predict Rapid Progression and Adverse Events of Patients with Idiopathic Inflammatory Myopathies-Related Interstitial Lung Disease.

Associated factors in the development of rapidly progressive interstitial lung disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis.

Performance of sit-to-stand, timed up-and-go, and six-minute walk tests in home and office settings in patients with idiopathic inflammatory myopathy.

Complementary and alternative medicine in dermatomyositis: A scoping review.

Utilization of Rehabilitation Services After Idiopathic Inflammatory Myopathy Diagnosis: A Retrospective Cohort Assessment in the United States.

Using serum cTnT/CK combined with anti-Ro52 antibodies to screen for myocardial involvement and assess prognosis in idiopathic inflammatory myopathy.

Pulmonary Involvement in Patients with Positive Myositis Antibodies in Rheumatology: A Retrospective Monocentric Analysis.

Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review.

Non-targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies.

Dermatomyositis: focus on cutaneous features, etiopathogenetic mechanisms and their implications for treatment.

Clinical significance of cytoplasmic discrete dots (AC-18) patterns in HEp-2 cell indirect Immunofluorescence: insights from a Taiwanese multicenter study.

The value of myositis-specific autoantibodies in the diagnosis of idiopathic inflammatory myopathy and tumor risk prediction.

Targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies.

Genetics of myositis - distinct backgrounds of subtypes.

Muscle strength recovery in patients with idiopathic inflammatory myopathy with different myositis-specific autoantibodies.

Clinicopathological profiling and prognosis of idiopathic inflammatory myopathy overlapping with myasthenia gravis: a retrospective cohort study.

Validation of the MCK model for predicting outcomes in myopathy-associated interstitial lung disease: a multicentre MYKO cohort study.

Advances in the Regulation by Immune Cells of Skeletal Myositis Outcomes.

Anti-nuclear matrix protein 2 antibody-positive dermatomyositis associated with smouldering myeloma mimicking anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: A case of digital gangrene, palmar papules, and scrotal rash.

Anifrolumab in Refractory Juvenile Dermatomyositis.

Clinical Significance and Correlation of Plasma D-Dimer, Fibrinogen, and Cytokines in Idiopathic Inflammatory Myopathy.

Coexistence of anti-melanoma differentiation-associated protein 5 and anti-Ro52 antibodies in patients with idiopathic inflammatory myopathy: a retrospective cohort study.

NXP-2-positive polymyositis associated with scrub typhus.

Polymyositis-Induced Atrial Flutter: A Rare and Unexpected Arrhythmia in an Idiopathic Inflammatory Myopathy.

The Prospective Registry Of MyositIS (PROMIS): II. Temporal shifts in causes of death among patients with idiopathic inflammatory myopathies.

N-glycosylation patterns of plasma immunoglobulin G in anti-synthetase syndrome disease.

The clinical features and mortality predictors for idiopathic inflammatory myopathies: a retrospective study of 572 patients and the "AIRMT" Score.

Chimeric Antigen Receptor T-cell therapy in systemic autoimmune rheumatic diseases: current insights and future prospects.

Expert consensus on interstitial lung disease associated with systemic autoimmune diseases. Executive summary.

Idiopathic Inflammatory Myopathies and Malignancy Screening: A Survey of Current Practices Amongst Canadian Neurologists and Rheumatologists.

Ruxolitinib in adult dermatomyositis with anti-TIF1γ antibody: a case report and literature review.

Risk, risk factors, and screening of malignancies in dermatomyositis: current status and future perspectives.

Muscle Vasculitis: A Novel Delineation of Distinct Subsets of Disease.

Immune Characterization of a Vietnamese Cohort With Idiopathic Inflammatory Myopathies.

Cardiac involvement in established idiopathic inflammatory myopathy assessed by cardiac magnetic resonance mapping.

Activated Dendritic Cell Subsets Characterize Muscle of Inclusion Body Myositis Patients and Correlate with KLRG1+ and TBX21+ CD8+ T cells.

Diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing for pulmonary infections in patients with connective tissue disease: A retrospective study.

Cardiac Magnetic Resonance Imaging Markers in Idiopathic Inflammatory Myopathy - A Prospective Observational Study.

Application of a Growth-Rate Model to Enhance Subgroup Identification in Heterogeneous Clinical Courses of the Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease and Its Prognostic Implication.

Myositis Due to Parvovirus B19: A Case Report and Literature Review.

Ageing Signatures and Disturbed Muscle Regeneration in Muscle Proteome of Inclusion Body Myositis.

A case of myositis associated with mixed connective tissue disease mimicking bilateral posterior interosseous nerve palsy.

Analysis of clinical features and risk factors for patients with idiopathic inflammatory myopathy complicated by Pneumocystis jirovecii pneumonia.

Association of Cancer and Anti-Synthetase Syndrome: A Retrospective Multicenter Study.

High levels of EPSTI1 enhance IFN-β-mediated HLA-A expression and chemokine secretion in myoblasts in dermatomyositis.

Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational study.

Characterizing local antibody responses in the muscle of inclusion body myositis patients.

Anti-HMGCR myopathy: a first case report from North Africa and literature insights.

Polymyositis Presenting With Respiratory Failure and Cardiac Arrest: A Case Report.

Beyond the Generalized Weakness: A Rare Case of Statin-Induced Immune-Mediated Necrotizing Myopathy.

Investigating the profile of patients with idiopathic inflammatory myopathies in the post-COVID-19 period.

Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases.

Serum connective tissue growth factor is aberrantly expressed in idiopathic inflammatory myopathy.

Differences in Organ Damage Based on Age at Onset in Idiopathic Inflammatory Myopathies: A Retrospective Multicenter MYKO Study.

Modeling Idiopathic Inflammatory Myopathy in the Bioinspired Muscle Tissue on Chip.

Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies.

Long-term outcomes of idiopathic inflammatory myopathies: a large-scale longitudinal cohort study.

Microvascular abnormalities between anti-TIF1-γ-associated dermatomyositis with and without malignancy.

Inclusion Body Myositis: A Case Report.

Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study.

Anti-TIF1-beta autoantibody-positive dermatomyositis: a case-based review.

Imaging assessment of calcinosis in juvenile dermatomyositis: a narrative review.

Abatacept for the treatment of myositis-associated interstitial lung disease.

Recruitment rate comparison between a virtual tele-research cohort and a traditional centre-based cohort in idiopathic inflammatory myopathy.

A novel approach to refractory idiopathic inflammatory myopathy: CD19 CAR T-cell therapy-case report and literature review.

MRI patterns of thigh muscle involvement in immune-mediated necrotizing myopathy and dermatomyositis.

Prevalence of Elevated CK Levels, Myositis-Specific and Myositis-Associated Antibodies, Myositis, and Other Neuromuscular Diseases in Myasthenia Gravis Patients-Experience from an Eastern European Tertiary Center.

Targeting B Cells for the Treatment of Idiopathic Inflammatory Myopathy.

Polymorphisms of HSP70 genes are involved in the pathogenesis of idiopathic inflammatory myopathy.

Mitochondrial damage is associated with an early immune response in inclusion body myositis.

The role of monocytes and macrophages in idiopathic inflammatory myopathies: insights into pathogenesis and potential targets.

Successful treatment of rheumatoid arthritis complicated by anti-Jo-1 antibody-positive myopathy with abatacept: A case report.

Risk factors and predictive model for pulmonary arterial hypertension in adult idiopathic-inflammatory-myopathy patients: A cross-sectional study.

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening recommendations detect most malignancies in patients with dermatomyositis: Retrospective performance in a tertiary-care center cohort.

MDA5 protein mediating persistent ER stress/unfolded protein response contributes to endothelial-mesenchymal-transition of lung microvascular endothelial cell in dermatomyositis.

Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study.

Pirfenidone alleviates interstitial lung disease in mice by inhibiting neutrophil extracellular trap formation and NLRP3 inflammasome activation.

Nailfold videocapillaroscopy findings are associated with IIM subtypes and IFN activation.

Pseudoangioedema as a presenting symptom of dermatomyositis with antinuclear matrix protein 2 autoantibodies.

Human epididymis secretory protein 4 in idiopathic inflammatory myopathy-associated interstitial lung disease.

Anti-nuclear Matrix Protein 2 Antibody-Positive Dermatomyositis Relapse With Preceding Panniculitis.

External validation of the 2017 EULAR/ACR classification criteria for idiopathic inflammatory myopathies in anti-MDA5 antibody-positive interstitial lung disease patients: A multicenter retrospective cohort study in China.

Plasma levels of adhesion molecules are elevated in dermatomyositis-interstitial lung disease and associated with low paraoxonase-1 activity.

Interleukin 6 inhibition in refractory antisynthetase syndrome: case-based literature review.

[Sequential autoimmunity? The rare case of MDA5 dermatomyositis and sarcoidosis].

Corrigendum: Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all.

Treatment guidelines for idiopathic inflammatory myopathies in adults: a comparative review.

Clinical Features of Dermatomyositis Associated with Myositis-Specific Antibodies in Moroccan Patients.

Characteristics of Overlap Syndrome in a Large Cohort of Brazilian Patients With Systemic Sclerosis: A Retrospective Analysis.

Patients with anti-PM/Scl-positive and idiopathic inflammatory myopathy resemble anti-synthetase syndrome.

Emerging mechanisms and therapeutics in inflammatory muscle diseases.

Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study.

Mortality Risk Prediction in Patients With Antimelanoma Differentiation-Associated, Gene 5 Antibody-Positive, Dermatomyositis-Associated Interstitial Lung Disease: Algorithm Development and Validation.

Dermatomyositis following resection of thyroid and breast cancer: a case report and literature review.

cGAS-STING mediates neutrophil extracellular traps-induced EMT in myositis-associated interstitial lung disease: STING as a potential therapeutic target.

Mitochondrial transplantation as a novel therapeutic approach in idiopathic inflammatory myopathy.

Clinical Characteristics and Outcomes of Patients with Anti-MDA5 Antibody Associated Rapidly Progressive Interstitial Lung Disease (RP-ILD): A Case Series.

Retrospective analysis of US veterans with inclusion body myositis: initial findings from the Veterans Affairs Corporate Data Warehouse.

Idiopathic inflammatory myopathy.

30-Color Longitudinal Full-Spectrum Immunophenotyping and Sorting of Human Circulating Immune Cell Subsets Implicated in Systemic Autoimmune Rheumatic Diseases.

Validity of Diagnosis Codes to Identify a Dermatomyositis Cohort from Electronic Health Records.

Recalcitrant Dermatomyositis Treated With Anifrolumab.

Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all.

Anti-SRP myositis: a diagnostic and therapeutic challenge.

Interstitial Lung Disease Associated with Anti-Ku Antibodies: A Case Series of 19 Patients.

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry.